UONDDL
RCKT icon

University of Notre Dame du Lac’s Rocket Pharmaceuticals RCKT Stock Holding History

University of Notre Dame du Lac’s Portfolio RCKT Stock Details RCKT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-171,015
Closed -$3M – 68
2019
Q1 		$3M Buy
171,015
+3,023
+2% +$47.7K 0.67% 46
2018
Q4 		$2.49M Buy
+167,992
New +$2.79M 0.6% 48

Other funds holding RCKT

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BM
Bridger Management New York $128M AUM 9.54% 1-Year Est. Return

University of Notre Dame du Lac's RCKT Position: Q2 2019 in Review

University of Notre Dame du Lac sold out of Rocket Pharmaceuticals (RCKT) in Q2 2019, closing a stake of 171,015 shares — an estimated $3M sold.

University of Notre Dame du Lac first reported a position in RCKT in Q4 2018 and held it in 2 quarters. The position peaked at $3M in Q1 2019. 96 funds tracked by Wall St. Rank hold RCKT as of Q2 2019.

  • University of Notre Dame du Lac reported no remaining Rocket Pharmaceuticals position as of Q2 2019 after selling out during the quarter.
  • University of Notre Dame du Lac sold 171,015 Rocket Pharmaceuticals shares in Q2 2019, an estimated $3M.
  • University of Notre Dame du Lac first reported a position in Rocket Pharmaceuticals in Q4 2018 and held it in 2 quarters.
  • University of Notre Dame du Lac's Rocket Pharmaceuticals position peaked at $3M in Q1 2019.
  • 96 funds tracked by Wall St. Rank held Rocket Pharmaceuticals as of Q2 2019.

Based on University of Notre Dame du Lac's 13F filing for Q2 2019, filed 14 Aug 2019.